Net Cash Provided by (Used in) Operating Activities in USD of KESTRA MEDICAL TECHNOLOGIES, LTD. from 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Kestra Medical Technologies, Ltd. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2023 to Q2 2025.
  • Kestra Medical Technologies, Ltd. Net Cash Provided by (Used in) Operating Activities for the quarter ending July 31, 2025 was -$26.3M, a 50.1% decline year-over-year.
  • Kestra Medical Technologies, Ltd. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$77.6M, a 7.44% decline from 2023.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$26.3M -$8.78M -50.1% May 1, 2025 Jul 31, 2025 10-Q 2025-09-12
Q2 2024 -$17.5M May 1, 2024 Jul 31, 2024 10-Q 2025-09-12

KESTRA MEDICAL TECHNOLOGIES, LTD. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$77.6M -$5.37M -7.44% May 1, 2024 Apr 30, 2025 10-K 2025-07-17
2023 -$72.2M May 1, 2023 Apr 30, 2024 10-K 2025-07-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.